 |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394 |
|
|
|
 |
Synopsis for October 19, 2001
The MMWR is not embargoed this week.
- Update: Investigation of Anthrax Associated With Intentional Exposure and Interim Public Health Guidelines October
2001
- Recognition of Illness Associated With the Intentional Release of a Biological Agent
- Weekly Update: West Nile Virus Activity United States, October 1016, 2001
Synopsis for October 19, 2001
Update: Investigation of Anthrax Associated With Intentional Exposure and Interim Public Health Guidelines October
2001
Four confirmed U.S. cases of anthrax have resulted from intentional use of Bacillus anthracis spores.
PRESS CONTACT:
Division of Media Relations
CDC, Office of Communication
(404) 6393286 |
|
These are the first confirmed cases of anthrax associated with intentional exposure. For rapid identification of threat agents, such as B.
anthracis, states should have access to the Laboratory Response Network for Bioterrorism which links state and local public health
laboratories with advanced capacity laboratories. Recommended regimens for postexposure prophylaxis are available. This report includes
information on the three clinical forms of anthrax (inhalation, gastrointestinal and cutaneous); recommended postexposure treatment regimens;
handling letters/packages and environmental management of exposed areas; handling laboratory specimens possibly infected with anthrax (for
healthcare providers); and handling anthrax and other biological agent threats (for the general public).
Recognition of Illness Associated With the Intentional Release of a Biological Agent
Following the terrorists incidents in New York City and Washington, D.C., CDC recommended heightened surveillance for any
unusual disease occurrences.
PRESS CONTACT:
Division of Media Relations
CDC, Office of Communication
(404) 6393286 |
|
This report provides basic guidance that can be implemented to improve recognition of potential biological agents. After the terrorist attacks
of September 11, 2001, state and local health departments initiated various activities to improve surveillance and response, ranging from
enhancing communications to conducting special surveillance projects. Healthcare providers, clinical laboratory personnel, infection control
professionals, and health departments play critical and complementary roles in recognizing and responding to illness caused by the release of
biologic agents. This report includes basic information for healthcare providers for recognizing anthrax, plague, botulism, smallpox,
inhalational tularemia, and hemorrhagic fever.
Weekly Update: West Nile Virus Activity United States, October 1016, 2001
PRESS CONTACT:
Division of Media Relations
CDC, Office of Communication
(404) 6393286 |
|
The report summarizes surveillance data for West Nile Virus (WNV) activities in the United States. The report includes information on human
cases and deaths, infected birds and other animals, and WNV-positive mosquito pools.
|
